Robert B Jones is President & CEO of Acura Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ACURA PHARMACEUTICALS, INC
20 Nov 23
4
ACURA PHARMACEUTICALS, INC
5 Jan 23
4
ACURA PHARMACEUTICALS, INC
5 Aug 22
4
ACURA PHARMACEUTICALS, INC
18 Mar 22
4
ACURA PHARMACEUTICALS, INC
6 Jan 21
4
ACURA PHARMACEUTICALS, INC
6 Jan 20
4
ACURA PHARMACEUTICALS, INC
17 Dec 18
4
ACURA PHARMACEUTICALS, INC
15 Dec 17
4
ACURA PHARMACEUTICALS, INC
11 Dec 17
4
ACURA PHARMACEUTICALS, INC
10 Aug 17
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Nov 23 | ACUR Acura Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 40,000 | 0.00 | 643,555 |
20 Nov 23 | ACUR Acura Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0.01 | 40,000 | 400.00 | 0 |
3 Jan 23 | ACUR Acura Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 50,000 | 0.00 | 603,555 |
3 Jan 23 | ACUR Acura Pharmaceuticals | RSU Common Stock | Option exercise | Acquire M | No | No | 0.01 | 50,000 | 500.00 | 40,000 |